Select Medical Holdings Corporation provided earnings guidance for the fourth quarter and year ended December 31, 2016. For the quarter, the company expects net income in the range of $17 million to $25 million, income tax expense in the range of $3 million to $5 million, income from operations in the range of $51 million to $61 million and adjusted EBITDA in the range of $92 million to $102 million. The company expects depreciation and amortization of $37 million and interest expense of $42 million. For the quarter, the company expects net income in the range of $17 million to $25 million, income tax expense in the range of $3 million to $5 million, income from operations in the range of $51 million to $61 million and adjusted EBITDA in the range of $92 million to $102 million. The company expects depreciation and amortization of $37 million and interest expense of $42 million. For the year, the company expects net income in the range of $122 million to $130 million, income tax expense in the range of $54 million to $56 million, income from operations in the range of $295 million to $305 million and adjusted EBITDA in the range of $460 million to $470 million. The company expects depreciation and amortization of $145 million and interest expense of $170 million. The company expects its net operating revenue for the full year 2016 to be approximately $4.286 billion.